Your search returned 10 results.

Results
	1.	STAT3 as a mediator of BCR-ABL1-independent resistance in chronic myeloid leukemia. [electronic resource] by Eiring, A M Kraft, I L Page, B D O'Hare, T Gunning, P T Deininger, M W Producer: 20160513 In: Leukemia supplements vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors. [electronic resource] by Traer, E MacKenzie, R Snead, J Agarwal, A Eiring, A M O'Hare, T Druker, B J Deininger, M W Producer: 20120705 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts. [electronic resource] by Lunsford, K E Jayanshankar, K Eiring, A M Horne, P H Koester, M A Gao, D Bumgardner, G L Producer: 20080703 In: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells. [electronic resource] by Lunsford, K E Horne, P H Koester, M A Eiring, A M Walker, J P Dziema, H L Bumgardner, G L Producer: 20061219 In: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia. [electronic resource] by Woessner, D W Eiring, A M Bruno, B J Zabriskie, M S Reynolds, K R Miller, G D O'Hare, T Deininger, M W Lim, C S Producer: 20151105 In: Leukemia vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [electronic resource] by Wagle, M Eiring, A M Wongchenko, M Lu, S Guan, Y Wang, Y Lackner, M Amler, L Hampton, G Deininger, M W O'Hare, T Yan, Y Producer: 20170726 In: Leukemia vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy. [electronic resource] by Khorashad, J S Tantravahi, S K Yan, D Mason, C C Qiao, Y Eiring, A M Gligorich, K Hein, T Pomicter, A D Reid, A G Kelley, T W Marth, G T O'Hare, T Deininger, M W Producer: 20180309 In: Leukemia vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. [electronic resource] by Eiring, A M Khorashad, J S Anderson, D J Yu, F Redwine, H M Mason, C C Reynolds, K R Clair, P M Gantz, K C Zhang, T Y Pomicter, A D Kraft, I L Bowler, A D Johnson, K Partlin, M Mac O'Hare, T Deininger, M W Producer: 20160413 In: Leukemia vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Age-related mutations and chronic myelomonocytic leukemia. [electronic resource] by Mason, C C Khorashad, J S Tantravahi, S K Kelley, T W Zabriskie, M S Yan, D Pomicter, A D Reynolds, K R Eiring, A M Kronenberg, Z Sherman, R L Tyner, J W Dalley, B K Dao, K-H Yandell, M Druker, B J Gotlib, J O'Hare, T Deininger, M W Producer: 20160915 In: Leukemia vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. [electronic resource] by Eiring, A M Page, B D G Kraft, I L Mason, C C Vellore, N A Resetca, D Zabriskie, M S Zhang, T Y Khorashad, J S Engar, A J Reynolds, K R Anderson, D J Senina, A Pomicter, A D Arpin, C C Ahmad, S Heaton, W L Tantravahi, S K Todic, A Colaguori, R Moriggl, R Wilson, D J Baron, R O'Hare, T Gunning, P T Deininger, M W Publication details: Leukemia 05 2017 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)